| Question 21 |
| Question 26.2 | |
| Question 26.1 | Label the CVVHDF circuit diagram |
| Question 23.3 | Causes of renal failure: interstitial nephritis due to β-lactams |
| Question 10 |
| Question 16.1 | Urinalysis in a neutropenic patient |
| Question 6 |
| Question 9.1 |
| Question 28 |
| Question 18 | Regional citrate for CRRT: basically everything about it |
| Question 8 |
| Question 28 | |
| Question 20.1 | |
| Question 13 | |
| Question 4.2 | Causes of rhabdomyolysis |
| Question 5.2 | Citrate toxicity: how will you change the dialysis prescription? |
| Question 1 | Rhabdomyolysis: causes, features, investigations and management |
| Question 29 |
| Question 7 |
| Question 15 | |
| Question 9.3 | Causes of renal failure: reabsorption of excreted wastes in bladder rupture |
| Question 26 | |
| Question 21 | |
| Question 19.2 | |
| Question 19.1 | Troubleshooting the dialysis circuit (haemolysis, causes of red effluent) |
| Question 19 |
| Question 5 | Rhabdomyolysis following head and neck surgery |
| Question 15 | Renal failure: protection from contrast, antibiotic dosing, indications for dialysis |
| Question 13.3 | Causes of renal failure: interstitial nephritis due to β-lactams |
| Question 29 |
| Question 21 | A comparison of renal replacement therapy modalities: CVVHF vs SLED vs IHD |
| Question 22 |
| Question 30 |
| Question 29 |
| Question 29 |
| Question 6.3 | Random uraemia: list of differentials for an electrolyte panel, with zero history. |
| Question 6.2 | Rhabdomyolysis following AAA repair |
| Question 12 | A critique of the RIFLE classification system. |
| Question 16 |
| Question 10 | A comparison of renal replacement therapy modalities: CVVHD vs SCUF vs IHD |
| Question 1 |
| Question 4 |
| Question 12 | |
| Question 2 | Biomarkers in assessment of acute kidney injury, eg urea:creatinine ratio |
| Question 12 | |
| Question 5.4 | |
| Question 5.3 | Troubleshooting the dialysis circuit (blood leak into the effluent) |
| Question 5.2 | Troubleshooting the dialysis circuit (very negative access pressure alarm) |
| Question 5.1 | Pre-dilution and post-dilution replacement fluid: advantages of pre-dilution. |
| Question 19 | A comparison of renal replacement therapy modalities: CVVHF vs SLED vs IHD. |
| Question 16 | |
| Question 11 | |
| Question 6.2 | Random uraemia: list of differentials for an electrolyte panel, with zero history. |
| Question 25 | A comparison of biochemical indices in diagnosis of pre-renal failure. |
| Question 14 |
| Question 24 | |
| Question 17 |
| Question 8 |
| Question 29 | Prevention of acute renal failure (contrast-induced nephropathy) in AAA repair. |
| Question 14 | |
| Question 4 |
| Question 6 |
| Question 5 |
| Question 1 |
| Question 2d | |
| Question 2c | |
| Question 2b | |
| Question 2a |